Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Recro Pharma Inc (NASDAQ:REPH)

6.94
BATS BZX Real-Time Price
As of 10:31am ET
 -0.10 / -1.42%
Today’s Change
5.81
Today|||52-Week Range
12.50
-13.90%
Year-to-Date
No recent news for Recro Pharma Inc.

Today’s Trading

Previous close7.04
Today’s open7.32
Day’s range6.83 - 7.35
Volume2,230
Average volume (3 months)169,144
Market cap$134.1M
Dividend yield--
Data as of 10:31am ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)-1,442.86%
Earnings growth (this year)+16.22%
Earnings growth (next 5 years)--
Revenue growth (last year)+33.46%
P/E ratioNM
Price/Sales1.25
Price/Book1.87

Competitors

 Today’s
change
Today’s
% change
--Verona Pharma PLC+0.02+1.30%
ADMPAdamis Pharmaceutica...-0.05-1.00%
CRMECardiome Pharma Corp+0.01+0.25%
TRVNTrevena Inc-0.03-1.40%
Data as of 10:16am ET, 06/28/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$69.3M
Annual profit (last year)-$30.2M
Net profit margin-43.56%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gerri Henwood
Chief Financial Officer
Michael Celano
Corporate headquarters
Malvern, Pennsylvania

Forecasts